No Long COVID Drugs Yet, But Other Treatments Available

0
156


Allison Saulino, 46, lengthy COVID advocate, Hilliard, OH.

David Putrino, PhD, director of rehabilitation innovation, Mount Sinai Well being System, New York Metropolis.

Andrew Schamess, MD, professor of inner medication, Ohio State Wexner Medical Middle, who runs the Publish-COVID Restoration Program.

Daniel Sterman, MD, director, Division of Pulmonary, Important Care and Sleep Drugs, NYU Langone Well being, New York Metropolis.

Jennifer Frontera, MD, neurologist, NYU Langone Well being.

Journal of Neurological Science: “Mid and Lengthy-Time period Neurological and Neuropsychiatric Manifestations of Publish-COVID-19 Syndrome: A Meta-Evaluation.”

American Academy of Otolaryngology: “Scent Retraining Remedy.”

PLOS Pathogens: “SARS-CoV-2-Particular T-Cells Affiliate with Irritation and Decreased Lung Operate in Pulmonary Publish-Acute Sequalae of SARS-CoV-2.”

Science Translational Drugs: ”SARS-CoV-2 An infection Produces Power Pulmonary Epithelial and Immune Cell Dysfunction with Fibrosis in Mice.”

Rheumatic & Musculoskeletal Illnesses: “Fibromyalgia: a New Side of the Publish-COVID-19 Syndrome Spectrum? Outcomes From A Net-Primarily based Survey.”

Journal of Thrombosis and Haemostasis: “Persistent Endotheliopathy within the Pathogenesis of Lengthy COVID Syndrome.”

Worldwide Discussion board of Allergy and Rhinology: “Budesonide Irrigation with Olfactory Coaching Improves Outcomes In contrast with Olfactory Coaching Alone in Sufferers with Olfactory Loss.”

Oregon Well being & Science College: “Scientific Tips: Lengthy COVID-19.”



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here